Denali Therapeutics Inc.

Founder of Bruker AXS, Inc., Molecular Dynamics, Inc. and Helix OpCo LLC, Jay T. Flatley is an entrepreneur and businessperson who has been at the head of 9 different companies and currently is Chairman of Helix Holdings I, LLC, Chairman for Iridia, Inc., Advisors at IIF Management Co. LLC and Advisor at Illumina Accelerator. Mr. Flatley is also Chairman for The Wellcome Trust Ltd. and Chairman at Wellcome Leap, Inc. and on the board of 6 other companies.

He previously held the position of Executive Chairman for Illumina, Inc. and Chairman for GRAIL LLC (a subsidiary of Illumina, Inc.), Vice President-Engineering & Strategic Planning at Plexus Computers LLC, Executive Vice President of Manning Technologies, Inc., Chairman at Zymergen, Inc., President, Chief Executive Officer & Director at Molecular Dynamics, Inc., President & Chief Executive Officer for Bruker AXS, Inc., Executive Vice President-Manning Technologies at Spectra-Physics, Inc. and Advisory board member at UCSD Medical Center.

Mr. Flatley received a graduate degree and an undergraduate degree from Stanford University and an undergraduate degree from Claremont McKenna College.